22 high-performance-quantum-computing-"https:"-"https:"-"https:"-"https:" positions at SciLifeLab
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. The position is based in the Computational Genomics Research (CGR) Lab, within the Data Science and AI division. About us The Department of Computer Science and Engineering , a joint department of Chalmers and
-
cutting-edge, high-density data-driven research that impacts academia, industry, and policy worldwide. About the Programme Fellowship: each participant will benefit from a 36-month postdoctoral training
-
of the largest pan-cancer signaling models in the literature. SPARCED is compatible with high-performance and cloud computing, can simulate thousands to millions of single-cell trajectories, is easily expandable
-
stage. Strong programming skills (Python or R) and familiarity with high-performance computing Exceptional collaborative abilities Preferred qualifications A doctoral degree or an equivalent foreign
-
of 3.3 billion SEK (about 350 MUSD) over 12 years from the Knut and Alice Wallenberg (KAW) Foundation. The DDLS program funds 50 high-profile young group leaders (“Fellows”), over 210 postdoctoral
-
of LNPs under various storage conditions, the aim is to develop formulations with both high performance and improved stability. The work includes the design and systematic screening of LNP formulations
-
large-scale, high-dimensional datasets including multi-modal data integration and hands-on experience with high-performance computing (HPC) environments Ability to work independently and in
-
capabilities in Sweden. The program is funded with a total of 3.3 billion SEK (about 350 MUSD) over 12 years from the Knut and Alice Wallenberg (KAW) Foundation. The DDLS program funds 50 high-profile young
-
the Human Evolution research program. The Ancient DNA unit is a team that includes staff from the Centre for Palaeogenetics (CPG), part of Stockholm University and the Swedish Museum of Natural History
-
, lineage-tracing, and computational approaches to address clinically relevant questions in cancer and drug development. Our work is carried out in close collaboration with national and international partners